Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clonality”

132 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 132 results

Testing effectiveness (Phase 2)Study completedNCT03227926
What this trial is testing

Rechallenge With Panitumumab Driven by RAS Dynamic of Resistance

Who this might be right for
Colorectal Cancer
Fondazione del Piemonte per l'Oncologia 32
Early research (Phase 1)WithdrawnNCT03196401
What this trial is testing

Durvalumab (Anti-PDL1) Plus Radiation Therapy for the Treatment of Solitary Bone Plasmacytoma

Who this might be right for
Solitary Bone Plasmacytoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05641831
What this trial is testing

Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study

Who this might be right for
Clonal Cytopenia of Undetermined Significance
Uma Borate 110
Testing effectiveness (Phase 2)Study completedNCT01036009
What this trial is testing

Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+7 more
University of California, San Francisco 43
Not applicableLooking for participantsNCT05710211
What this trial is testing

Clonal Architecture of ASXL1-mutated Myelofibrosis

Who this might be right for
Myelofibrosis
University Hospital, Angers 50
Testing effectiveness (Phase 2)Looking for participantsNCT03418038
What this trial is testing

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Who this might be right for
Clonal Cytopenia of Undetermined SignificanceHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRecurrent Diffuse Large B-Cell Lymphoma+5 more
Mayo Clinic 80
Not applicableStudy completedNCT03059641
What this trial is testing

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China

Who this might be right for
Lung NeoplasmsLung Cancer, Nonsmall CellAdenocarcinoma of Lung+1 more
Geneplus-Beijing Co. Ltd. 300
Not applicableLooking for participantsNCT05711173
What this trial is testing

Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)

Who this might be right for
Venous ThrombosesThromboembolic DiseaseNeutrophil Extracellular Trap Formation+1 more
University Hospital, Bordeaux 150
Not applicableStudy completedNCT05146414
What this trial is testing

Clonal Hematopoiesis of Indeterminate Potential and Accelerated Atherosclerosis in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Assistance Publique - Hôpitaux de Paris 500
Testing effectiveness (Phase 2)Study completedNCT02183883
What this trial is testing

Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity

Who this might be right for
Non-small Cell Lung Cancer
University College, London 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05030441
What this trial is testing

Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1

Who this might be right for
Clonal Cytopenia of Undetermined Significance
Washington University School of Medicine 20
Not applicableStudy completedNCT00665067
What this trial is testing

Correlative Biomarker Study in Patients With Myeloproliferative Disorders

Who this might be right for
Myeloproliferative DiseaseMyelofibrosisIdiopathic Myelofibrosis+2 more
Icahn School of Medicine at Mount Sinai 592
Not applicableNot Yet RecruitingNCT05969821
What this trial is testing

Clonal Hematopoiesis of Immunological Significance

Who this might be right for
Immune System DiseasesAutoimmune DiseasesInflammation+13 more
Assistance Publique - Hôpitaux de Paris 5,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07435636
What this trial is testing

Modulation of Stem Cell Differentiation in Individuals With High Risk Clonal Haematopoiesis

Who this might be right for
Clonal Cytopenia of Uncertain SignificanceCCUS Clonal Cytopenia of Undetermined SignificanceClonal Hematopoiesis
Clinical Hub for Interventional Research (CHOIR) 80
Not applicableLooking for participantsNCT06379945
What this trial is testing

Unified platforM for a Better integRal Evaluation of MyeLodyspLastic Syndromes in SpAin-Strategy for Unraveling Personalized genoMic Medicine in Public heAlth System (UMBRELLA-SUMMA)

Who this might be right for
Myelodysplastic Syndromes
Instituto de Investigación Biomédica de Salamanca 300
Not applicableEnrolling By InvitationNCT06584994
What this trial is testing

Investigating the Role of Genetics in Disease Predisposition

Who this might be right for
Predisposition, GeneticCancerMutation+1 more
The Wellcome Sanger Institute 1,000
Not applicableUnknownNCT01326741
What this trial is testing

Clonal Mast Cell Disorders in Exercise-Induced Anaphylaxis

Who this might be right for
Anaphylaxis
Brigham and Women's Hospital 10
Not applicableNot Yet RecruitingNCT06244069
What this trial is testing

Clonal Hematopoiesis in Giant Cell Arteritis

Who this might be right for
Giant Cell ArteritisTemporal ArteritisClonal Hematopoiesis of Indeterminate Potential+2 more
ASST Fatebenefratelli Sacco 326
Not applicableLooking for participantsNCT03190928
What this trial is testing

Clonal Evolution in Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
National Cancer Institute (NCI) 200
Not applicableLooking for participantsNCT06523374
What this trial is testing

Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer

Who this might be right for
Barrett's EsophagusEsophageal Adenocarcinoma
University Hospital, Antwerp 50
Load More Results